SCHEMBL9059656

SCHEMBL9059656

Cc1ccc(-c2ccccc2N=C(N)N(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.43
CYP2D6 P10635 1/20 0.37
HIF1A Q16665 1/20 0.37
HTR3E A5X5Y0 1/20 0.35
SLC22A2 O15244 1/20 0.35
SLC22A1 O15245 1/20 0.35
SLC22A3 O75751 1/20 0.35
HTR3B O95264 1/20 0.35
PLAU P00749 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 1/20 0.35
GFER P55789 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
POLB P06746 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9311667 0.86 SIGMAR1 (0.41) SIGMAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL9059579 0.83 SIGMAR1 (0.48) SIGMAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL9311522 0.74 GRIN2D (0.46) SIGMAR1
SCHEMBL6269790 0.73 RAB9A (0.42) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL9059756 0.71 SIGMAR1 (0.50) SIGMAR1MEN1KMT2A
SCHEMBL9539364 0.71 SIGMAR1 (0.41) SIGMAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL9059299 0.70 SIGMAR1 (0.53) SIGMAR1MAPTKDM4EALDH1A1GAA
SCHEMBL13967962 0.70 SIGMAR1 (0.47) SIGMAR1MEN1KMT2AKDM4EALDH1A1
SCHEMBL9059298 0.70 SIGMAR1 (0.53) SIGMAR1MAPTKDM4EALDH1A1GAA
SCHEMBL9060002 0.70 SIGMAR1 (0.40) SIGMAR1RAB9AMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed